Although overexpression of miR-17–92 in CD4+ T cells results in an increased frequency of Tfr cells (98), it has been proposed that miR-17–92 suppresses Tfr cell generation in mice with chronic graft-versus-host disease (100). The gene discussed is TFRC; the disease is chronic graft versus host disease.